Guest guest Posted August 20, 2011 Report Share Posted August 20, 2011 Bob: 1. Regarding your note: " BTW, I am sure you noticed that the Mycologia article was JOINTLY authored by Larry on, PhD. Former President of IAQA. He also references as the most significant historical researcher. " Response: a. Why should I care who the co-author is (no offense to Mr. on). The way I view it, it is a question of what the article consists of, not who wrote it. If Einstein wrote it, I'd still evaluate it the same, although I'd likely be more careful on checking my evaluation before reporting it. b. As for as the " most significant " . The Mycologia article states was the " first to characterize the presence of fungal spores in the atmosphere " . This " who was first " was the point that I disagree with - he certainly was not the first, and he did not do it in 1789 but rather 1879. By the way, Maddox was an MD as was Sigerson. Sigerson was Ireland's first neurosurgeon and a Fellow of the Linnean Society. He had an MD from Queens Univ in Ireland and a Master in Surgery (MCh) from there as well, and he graduated top of his class at St. Joe College in France (bachelors). He was a published poet at age 21, he tested application of metals to the skin to treat illness, as well as using electro-therapy. He also served as a Senator in Ireland and played politics fairly well. Very much a renaissance man. 2. Regarding my question: 'So what do you define as " sensitive " person in the PRV book?' [in response to your statement about the PRV book: the only reference I am aware of that SPECIFICALLY states that PRV testing should be done for " sensitive populations " ] You responded by: a. Explaining " high-risk populations " as used in the PRV book And b. Stating " Sensitive individuals is a term used by AAAI " (presumably not in the PRV book) And c. Stating " people who develope(sic) SBS syndrome. They are also sensitive individuals. " (presumably not in the PRV book) So a couple of questions, since I'm not getting it: Q1: Does the PRV book use the term " sensitive populations " when recommending PRV testing? If so, where? Q2: Where is " sensitive populations " (or persons) defined in the PRV book? Tony Ps Still out of the office. Hopefully back in soon. ....................................................................... " Tony " Havics, CHMM, CIH, PE pH2, LLC 5250 E US 36, Suite 830 Avon IN 46123 www.ph2llc.com off fax cell 90% of Risk Management is knowing where to place the decimal point...any consultant can give you the other 10%(SM) This message is from pH2. This message and any attachments may contain legally privileged or confidential information, and are intended only for the individual or entity identified above as the addressee. If you are not the addressee, or if this message has been addressed to you in error, you are not authorized to read, copy, or distribute this message and any attachments, and we ask that you please delete this message and attachments (including all copies) and notify the sender by return e-mail or by phone at . Delivery of this message and any attachments to any person other than the intended recipient(s) is not intended in any way to waive confidentiality or a privilege. All personal messages express views only of the sender, which are not to be attributed to pH2 and may not be copied or distributed without this statement. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.